List/Grid Sci & Health
Chicago, January 4, 2016 – The New Roseland Community Hospital welcomes Patrice R. Frederick, MD as the Southside Safety Net Hospital’s new Medical Director of Surgery. Dr. Frederick, born and…
Orland Park, Ill.– Kathleen Drinan DO, FACC, a local cardiologist in private practice, has recently been awarded Diplomate status with the Accreditation Council for Clinical Lipidology (ACCL). The ACCL is…
Online Web Service Masagio Offering Same Day, In-Home Massages With Talented, Licensed Massage Therapists!
Masagio launches ground-breaking new service that lets those living in Chicago log onto the Internet to book same day, in-home massages with talented, licensed massage therapists. CHICAGO – July 21,…
June 10, 2015 John (Sean) Mullan, MD, the John Harper Seely Professor Emeritus in the Department of Surgery at the University of Chicago, died from lung cancer on Thursday, June 4, surrounded by family members at his home in Hyde Park. He was 90 years old.
ICeChIP technique enables accurate, repeatable measurements in epigenetic studies for the first time June 4, 2015 One of the most widely used tools in epigenetics research — the study of how DNA packaging affects gene expression — is chromatin immunoprecipitation (ChIP), a technique that allows researchers to examine interactions between specific proteins and genomic regions. However, ChIP is a relative measurement, and has significant limitations that can lead to errors, poor reproducibility and an inability to be compared between experiments.
June 2, 2015 Preterm births continue to be a critical health problem in this country, despite all the medical knowledge about babies born too soon and the modern technology used to treat them. While the critical challenges facing babies born before 37 weeks are known and well-documented, what is not understood are the causes a woman goes prematurely into labor.
Available genetic data could help doctors choose safer, more effective drugs for patients taking cardiovascular medicines
June 1, 2015 There is a wealth of published information describing interactions between drugs used to treat cardiovascular disease and the genetic variations that can affect how patients respond to them. But few heart specialists make routine use of this potentially life-saving data.
May 29, 2015 Immunotherapy with the anti-PD-1 antibody pembrolizumab (Keytruda®) was effective in one out of four patients with recurrent or metastatic head and neck cancer, according to results presented at the 2015 meeting of the American Society for Clinical Oncology (ASCO). Pembrolizumab decreased the size of tumors by 30 percent or more in 24.8 percent of 132 patients, making it nearly twice as effective as the current preferred treatment using platinum-based chemotherapy plus cetuximab, an epidermal growth factor inhibitor.
May 22, 2015 China Century Group and the University of Chicago Medicine signed an exclusive agreement Thursday to improve health care delivery in China by bringing international standards and best practices to hospitals across the country. “Our enterprise is expanding its activities into the health care sector by investing in and managing hospitals,” said Chen Liguang, founder, chairman and CEO of China Century Group Inc., which already operates in the energy, technology and real estate sectors.
May 20, 2015 Several recent studies have suggested that metformin, an established drug developed to treat patients with type II diabetes, may provide significant benefits, including increased survival, to patients being treated for advanced cancers. An analysis of combined results from these earlier studies found that metformin use was associated with a significant decrease in cancer risk, tumor burden and cancer mortality.